Literature DB >> 17466893

Fresh frozen plasma as a complement source.

Ronald Taylor.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17466893     DOI： 10.1016/S1470-2045(07)70114-6

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  7 in total

1.  NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complement.

Authors:  Siao-Yi Wang; Emilian Racila; Ronald P Taylor; George J Weiner
Journal:  Blood       Date:  2007-11-16       Impact factor: 22.113

Review 2.  Is complement good or bad for cancer patients? A new perspective on an old dilemma.

Authors:  Maciej M Markiewski; John D Lambris
Journal:  Trends Immunol       Date:  2009-05-08       Impact factor: 16.687

3.  Exhaustion of cytotoxic effector systems may limit monoclonal antibody-based immunotherapy in cancer patients.

Authors:  Frank J Beurskens; Margaret A Lindorfer; Mohammed Farooqui; Paul V Beum; Patrick Engelberts; Wendy J M Mackus; Paul W H I Parren; Adrian Wiestner; Ronald P Taylor
Journal:  J Immunol       Date:  2012-02-24       Impact factor: 5.422

Review 4.  Antigenic modulation and rituximab resistance.

Authors:  Ronald P Taylor; Margaret A Lindorfer
Journal:  Semin Hematol       Date:  2010-04       Impact factor: 3.851

Review 5.  Anti-CD20 monoclonal antibodies: historical and future perspectives.

Authors:  Sean H Lim; Stephen A Beers; Ruth R French; Peter W M Johnson; Martin J Glennie; Mark S Cragg
Journal:  Haematologica       Date:  2009-09-22       Impact factor: 9.941

Review 6.  Complement as driver of systemic inflammation and organ failure in trauma, burn, and sepsis.

Authors:  Marco Mannes; Christoph Q Schmidt; Bo Nilsson; Kristina N Ekdahl; Markus Huber-Lang
Journal:  Semin Immunopathol       Date:  2021-06-30       Impact factor: 9.623

7.  Complement depletion deteriorates clinical outcomes of severe abdominal sepsis: a conspirator of infection and coagulopathy in crime?

Authors:  Jianan Ren; Yunzhao Zhao; Yujie Yuan; Gang Han; Weiqin Li; Qian Huang; Zhihui Tong; Jieshou Li
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.